25 of the Best Urologists Near Me in Mount Vernon, NY

Stephen Trauzzi is a Urologist in New Rochelle, New York. Dr. Trauzzi is highly rated in 36 conditions, according to our data. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Prostatectomy, and Ureteroscopy.

Marc Janis is a Urologist in Mount Vernon, New York. Dr. Janis is highly rated in 34 conditions, according to our data. His top areas of expertise are Male Pseudohermaphroditism with Gynecomastia, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Ureteroscopy, and Prostatic Artery Embolization.

Thomas Rechtschaffen is a Urologist in Yonkers, New York. Dr. Rechtschaffen is highly rated in 27 conditions, according to our data. His top areas of expertise are Interstitial Cystitis, Enlarged Prostate (BPH), UPJ Obstruction, Ureteroscopy, and Prostatectomy.

Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program. Dr. Watts is highly rated in 10 conditions, according to our data. Her top areas of expertise are Prostate Cancer, Kidney Stones, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Alexander I. Sankin, MD, is Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer. Dr. Sankin is highly rated in 7 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Ureteroscopy.

Alexander C. Small, MD, is an Attending Physician and Assistant Professor at Montefiore-Einstein. Dr. Small specializes in the treatment of urological diseases, cancer and kidney stones through the use of minimally invasive, robotic and endoscopic surgery. Dr. Small is highly rated in 6 conditions, according to our data. His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), Ureteroscopy, and Lithotripsy.

Dima Raskolnikov, MD, is an attending physician and Assistant Professor, Urology at Montefiore Einstein. Dr. Raskolnikov specializes in minimally invasive surgery with a focus on complex kidney stone disease, robotic urinary tract reconstruction and kidney cancer. Dr. Raskolnikov is highly rated in 4 conditions, according to our data. His top areas of expertise are Kidney Stones, Prostate Cancer, Boils, Ureteroscopy, and Lithotripsy.

Michael Gross is a Urologist in Bronx, New York. Dr. Gross has been practicing medicine for over 44 years is highly rated in 24 conditions, according to our data. His top areas of expertise are Balanitis, Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Prostatectomy.

Eric Kreutzer is a Urologist in Bronx, New York. Dr. Kreutzer is highly rated in 19 conditions, according to our data. His top areas of expertise are Enlarged Prostate (BPH), Folliculitis, Carbuncle, and Boils.

Michael Grasso is a Urologist in Sleepy Hollow, New York. Dr. Grasso is highly rated in 42 conditions, according to our data. His top areas of expertise are UPJ Obstruction, Boils, Retroperitoneal Fibrosis, Ureteroscopy, and Reconstructive Urology Surgery.

Zeph Okeke, MD is a board certified urologic surgeon specializing in endourology, minimally invasive surgery and laparoscopy. He is known for developing and being the principal investigator of the novel S.T.O.N.E. classification system for kidney stones.His expertise is in using minimally invasive techniques for the management of complex kidney and ureteral stone disease, and urothelial cancers (transitional cell carcinoma) of the kidney and ureter. He also has special interest and expertise in Holmium and Thulium laser enucleation (HOLEP and ThuLEP) for enlarged prostates (BPH).In addition to treating patients and conducting research, Dr. Okeke serves as co-director of the Smith Institute for Urology endourology and laparoscopy fellowship training programs. He lectures at the American Urological Association s annual meetings and is frequently invited to speak before the World Congress of Endourology. A mentor and teacher, Dr. Okeke also serves as a surgeon and lecturer for live surgical demonstration courses at various international meetings.Dr. Okeke earned his medical degree from Cornell University Medical College in New York City. He completed his Urology residency and served as Chief Resident in the Department of Urology at the New York Presbyterian Hospital-Columbia University College of Physicians & Surgeons.Dr. Okeke's research interest includes surgical outcomes of kidney stone patients, grading and characterizing complex kidney stones to guide surgery and counseling with respect to outcomes. He has published in leading journals and textbooks including the Smith's Textbook of Endourology, Journal of Urology, Urology and Cancer.He is the recipient of the Teacher of the Year Award at the North Shore LIJ Health System. Dr. Okeke also received the prestigious Arnold P. Gold Foundation Teaching Award for Humanism and Excellence in Teaching. Columbia University College of Physicians & Surgeons awarded its first Lifetime Achievement Award to Dr. Okeke for medical student teaching during his residency. Dr. Okeke is highly rated in 33 conditions, according to our data. His top areas of expertise are Kidney Stones, Horseshoe Kidney, Bladder Stones, Ureteroscopy, and Endoscopy.

David M. Hoenig, MD, is a specialist in kidney stone treatment and minimally invasive surgery, including laparoscopic surgery. His specific clinical interests include all phases of kidney stone disease, from surgical treatment, to medical management, and to prevention. Dr. Hoenig completed medical school at the University of Rochester (Rochester, NY), and residency in Urology at Brown University (Providence, RI). He went on to one of the premier Laparoscopy and Endourology Fellowships in the country, under Dr. Ralph V. Clayman, one of the pioneers of minimally invasive urologic surgery, at Washington University (St. Louis, MO).After Fellowship training, Dr. Hoenig became a Clinical Instructor at the Medical College of Pennsylvania/Hahnemann under the auspices of Allegheny University, and was then recruited to Montefiore Medical Center/Albert Einstein College of Medicine to become the Director of Laparoscopy and Endourology and promoted to Assistant Professor. While at Montefiore, Dr. Hoenig assumed many administrative roles, as co-founder and co-Director of the Robotic, Laparoscopy, and Endourology Fellowship, Residency Program Director, and Practice Manager. After more than 14 years at Montefiore/Albert Einstein, he was recruited to North Shore- Long Island Jewish Hospital in 2013 with a promotion to Professor, and a shift of administrative roles to Chief of Urology Service at LIJ Hospital Campus. Dr. Hoenig's research interests are in all phases of minimally invasive urologic surgery, with particular attention to kidney stone disease, and both ablative and reconstructive minimally invasive renal surgery. His most recent publications explore the association of obesity with urological diseases, with new associations discovered between types of obesity and certain kidney stones. This research focus is a priority, given the national trend of increasing obesity, and will lead to exciting basic science exploration of these conditions.As a clinician, Dr. Hoenig's priority is treating patients with respect and empathy. He believes strongly in educating patients about their conditions, so as to equip them with the necessary information to make them a partner in their health care. Dr. Hoenig is highly rated in 31 conditions, according to our data. His top areas of expertise are Kidney Stones, Medullary Sponge Kidney, Perirenal Abscess, Ureteroscopy, and Endoscopy.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is highly rated in 25 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Dr. Lerner received his Medical Degree with honors (cum laude) from the State University of New York Health Science Center at Brooklyn, New York. He was elected as a member to the Alpha Omega Alpha, Honor Medical Society. Dr. Lerner is highly rated in 23 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Hagge-Greenberg is the Chief of the Urology Department at White Plains Hospital. He received his Medical Degree from the State University of New York Downstate College of Medicine, Brooklyn, New York. He completed a Surgical Internship and a Urology Residency at the Albert Einstein College of Medicine, Montefiore Medical Center in the Bronx. Dr. Hagge-Greenberg obtained a Fellowship in Female Pelvic Medicine and Robotic Reconstructive Surgery at Albert Einstein/Montefiore. Dr. Hagge is highly rated in 22 conditions, according to our data. His top areas of expertise are UPJ Obstruction, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Prostatectomy.

Guarionex Decastro is a Urologist in New York, New York. Dr. Decastro is highly rated in 21 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Decastro is currently accepting new patients.

Dr. Glassman has been practicing general and pediatric urology for over 35 years in Westchester. Dr. Glassman's most recent focus is on minimally invasive procedures for the treatment of benign prostatic gland enlargement (BPH) and erectile dysfunction. Dr. Glassman is highly rated in 21 conditions, according to our data. His top areas of expertise are Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Urinary Tract Infection in Children, and Ureteroscopy.

"Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University.Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as ""Best Reviewer"" in 2014 by The Journal of Urology and in 2016 by Cancer.Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.". Dr. Anderson is highly rated in 20 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is highly rated in 19 conditions, according to our data. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy.

Dr. Fara Bellows is a Board-Certified urologist and urologic surgeon at WPHPA. Dr. Bellows is highly rated in 17 conditions, according to our data. Her top areas of expertise are Urinary Incontinence, Stress Urinary Incontinence, Neurogenic Bladder, Ureteroscopy, and Prostatectomy.

Ahmed Aboumohamed, MD is an Attending Physician and a Professor in the Department of Urology at Montefiore and our Albert Einstein College of Medicine. Dr. Aboumohamed's areas of expertise include urology, urologic oncology, minimally invasive and robotic surgery, and urologic reconstruction. Dr. Aboumohamed is highly rated in 10 conditions, according to our data. His top areas of expertise are Bilateral Hydronephrosis, Bladder Cancer, Hydronephrosis, Cystectomy, and Nephrectomy.

Dr. Fleischmann received her Medical Degree from the State University of New York, Health Science Center at Brooklyn, graduating summa cum laude. While there, she received the Janet M. Glasgow Memorial Achievement Citation from the American Medical Women's Association for Highest Academic Achievement, and was a member of the Alpha Omega Alpha honors society and Pathology Honors Society. Dr. Fleischmann is highly rated in 9 conditions, according to our data. Her top areas of expertise are Urinary Incontinence, Stress Urinary Incontinence, Uterine Prolapse, Urinary Tract Infection in Children, and Ureteroscopy.

I am a physician dedicated to improving patient care. I completed my training at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. I focus on a wide array of interventional radiological and surgical techniques, including image guided procedures, focal prostate cancer therapy, prostate artery embolization and much more.I hope that you find our practice a place of caring, education and access to some of the latest therapies in prostate cancer care as well as treatments for enlarged prostates. Dr. Rastinehad is highly rated in 6 conditions, according to our data. His top areas of expertise are Prostate Cancer, Enlarged Prostate (BPH), Familial Prostate Cancer, Prostatic Artery Embolization, and Prostatectomy.

Franklin C. Lowe, MD, Professor of Urology and Vice-Chair of the Department, is also Director of Urologic Services, Jack D. Weiler Hospital. An expert in the treatment of benign and malignant disorders of the prostate, Dr. Lowe has published over 150 articles on multiple urological topics and has lectured extensively throughout the world. Prior to joining The Department of Urology at Montefiore, Dr. Lowe held faculty and leadership positions at Columbia University, Mount Sinai School of Medicine and at St. Luke’s/ Roosevelt Hospital in Manhattan. A Graduate of Princeton University, Dr. Lowe obtained both his Medical and Masters of Public Health degrees from Columbia University College of Physicians and Surgeons. He completed his internship and residency in Surgery and Urology at The James Buchanan Brady Urological Institute of Johns Hopkins University. Dr. Lowe previously served as the Chairman of The American Urological Association’s Alternative Medicine Committee and as a member of the BPH Guidelines Committee. Dr. Lowe is highly rated in 3 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Ureteroscopy.

Stephen W. Reese, MD, is an attending physician at Montefiore Einstein and Assistant Professor at our Albert Einstein College of Medicine. Dr. Reese cares for patients with urologic cancers, using minimally invasive and open surgical approaches. He has a particular interest in the management of urologic cancers, including kidney, prostate, bladder, adrenal and testicular cancer and works to care for patients in a multidisciplinary setting with his colleagues in medical and radiation oncology. In 2017, Dr. Reese received his Doctor of Medicine at Boston University School of Medicine. He completed his residency training at Brigham and Women’s Hospital in Boston, MA in 2022 and then completed a Society of Urologic Oncology (SUO) Fellowship at Memorial Sloan Kettering Cancer Center in 2024. Dr. Reese is highly rated in 2 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Venous Thromboembolism (VTE), Renal Oncocytoma, Nephrectomy, and Cystectomy.